隐源性卒中 – Medxy AI

Hypertension-Related High-Risk Features May Identify Which Patients With Cryptogenic Stroke Benefit From Apixaban Instead of Aspirin

By MedXY 06/10/2026

An exploratory ARCADIA analysis suggests that patients with cryptogenic stroke and atrial cardiopathy without severe hypertension-related features may derive greater benefit from apixaban than aspirin, whereas those with high-risk hypertensive features may not.

Hematology-Oncology Neurology news

Application of the AHA-Proposed Cancer-Related Ischemic Stroke Classification: Reclassification and Prognostic Impact

By MedXY 06/03/2026

The AHA-proposed CRIS classification reclassified many cancer-associated strokes previously labeled cryptogenic and identified a subgroup with markedly worse survival, improving both etiologic clarity and prognostic stratification.

Infectious Diseases Neurology news

Hidden Triggers: Recent Infections Linked to a 2.6-Fold Increase in Cryptogenic Stroke Risk in Young Adults

By MedXY 03/30/2026

The SECRETO study reveals that infections within the preceding week significantly increase the risk of cryptogenic ischemic stroke in patients aged 18–49, with elevated von Willebrand Factor and Factor VIII levels serving as critical biomarkers of this thromboinflammatory response.

Infectious Diseases Neurology news

Recent Infections Act as a Transient Trigger for Cryptogenic Stroke in Young Adults via Thromboinflammatory Pathways

By MedXY 03/18/2026

The SECRETO study demonstrates that infections within the preceding week increase the odds of cryptogenic ischemic stroke by 2.6-fold in young adults, primarily driven by transient increases in von Willebrand Factor and Factor VIII levels.

Cardiology Neurology news

Ultra-Early ILR Implantation Post-Cryptogenic Stroke Dramatically Improves Silent AF Detection: Insights from the CRIPTOFAST Trial

By MedXY 01/22/2026

The CRIPTOFAST trial demonstrates that ultra-early implantation of internal loop recorders significantly increases silent atrial fibrillation detection in cryptogenic stroke patients, particularly those with subtle left atrial anomalies, offering a targeted approach to secondary stroke prevention.